Fatheya F Al Awadi

7PUBLICATIONS
15CO-AUTHORS
Epidemiological methodsWastewater treatment processesMicroelectromechanical systems (MEMS)Gene expression (incl. microarray and other genome-wide approaches)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2026
Risk of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis: a large-scale study from the Middle East.

|Dec 24, 2025
Correction to: Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab Emirates.

Mohamed Farghaly, Olivier Cristeau, Fatheya Al Awadi

|Oct 21, 2025
Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab Emirates.

Mohamed Farghaly, Olivier Cristeau, Fatheya Al Awadi

|Jan 25, 2025
Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes.

Fatima Sulaiman, Costerwell Khyriem, Stafny Dsouza

|Jan 22, 2025
Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes.

Farooq Khan, Stafny Dsouza, Amar Hassan Khamis

|Dec 17, 2024
Risk of Microvascular Complications in Newly Diagnosed Type 2 Diabetes Patients Using Automated Machine Learning Prediction Models.

Amar Khamis, Fatima Abdul, Stafny Dsouza

Pageof 2

Frequent Collaborators

3 joint publications

Amar Khamis

3 joint publications

Stafny Dsouza

3 joint publications

Muhammad Hamed Farooqi

3 joint publications

Riad Bayoumi